As many Americans remain skeptical toward the race to release a COVID-19 vaccine, the poll examined how many respondents reported having a “great deal” and “fair amount” of trust in the pharmaceutical industry and the FDA.
Six percent of respondents reported having a great deal of trust in the pharmaceutical industry. Here are the results broken down by demographics:
- Age 18-29: 6 percent
- Age 30-49: 7 percent
- Age 50-64: 6 percent
- Age 65+: 6 percent
- White: 5 percent
- Black: 7 percent
- Latinx: 11 percent
- Rural: 4 percent
- Suburban: 6 percent
- Urban: 7 percent
Eight percent of respondents reported having a great deal of trust in the FDA. Here are the results broken down by demographics:
- Age 18-29: 9 percent
- Age 30-49: 8 percent
- Age 50-64: 9 percent
- Age 65+: 8 percent
- White: 7 percent
- Black: 9 percent
- Latinx: 13 percent
- Rural: 5 percent
- Suburban: 8 percent
- Urban: 11 percent
More articles on pharmacy:
Gilead expands oncology portfolio, acquires Immunomedics for $21B
8 considerations to take when preparing for COVID-19 vaccine distribution
‘We’re not finished with remdesivir’: Gilead CEO says trials underway for inhaled version, outpatient IV version
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
